PI3Kγ inhibition: towards an 'aspirin of the 21st century'?
Year: 2006
Type: review
Source: Nature Reviews Drug Discovery
DOI: 10.1038/nrd2145
Institution: Merck Serono S.A. (Switzerland)
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2018343427
